ENTA — ENANTA PHARMACEUTICALS INC

Ownership history in Commodore Capital LP  ·  4 quarters on record

This page tracks every 13F SEC filing in which Commodore Capital LP reported a position in ENANTA PHARMACEUTICALS INC (ENTA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.57% (2022 Q4)
Avg. % of fund
1.06%
First filed
2022 Q3
Last filed
2025 Q3
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 800,000 +582,747 +268.2% 0.47% $9.6M $11.97
2023 Q1 REDUCED 217,253 -6,241 -2.8% 1.34% $8.8M $40.44
2022 Q4 ADDED 223,494 +120,000 +115.9% 1.57% $10.4M $46.52
2022 Q3 INITIATED 103,494 — — 0.86% $5.4M $51.87
% of Fund (quarterly)    ENTA price (monthly, adj. close)

Other funds also holding ENTA

As of 2025 Q4 — sorted by position size

Krensavage Asset Management, LLC 3Y 7Y 15.41% Stonepine Capital Management, LLC 3Y 7Y 1.15% Deep Track Capital, LP 3Y 0.55% FARALLON CAPITAL MANAGEMENT LLC 3Y 7Y 0.21% Hillsdale Investment Management Inc. 3Y 7Y 0.18% Opaleye Management Inc. 3Y 7Y 0.16% Persistent Asset Partners Ltd 0.12% Sio Capital Management, LLC 3Y 7Y 0.1% Informed Momentum Co LLC 3Y 7Y 0.07% PDT Partners, LLC 3Y 7Y 0.07%
← Back to Commodore Capital LP Holdings